Sarcos Technology and Robotics Corporation to Participate in Upcoming Investor Conference
November 22, 2021 09:00 ET
|
Sarcos Corp.
SALT LAKE CITY, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Sarcos Technology and Robotics Corporation (“Sarcos”) (NASDAQ: STRC and STRCW) will participate in the following investor conference on Wednesday,...
EDAP Reports Third Quarter 2021 Results and Provides Operational Update
November 17, 2021 16:35 ET
|
EDAP TMS S.A.
Year-to-date revenue of approximately EUR 30.1 million (USD 35.9 million) increased 14.4% year-over-year Q3 revenue of EUR 9.4 million (USD 11.1 million), flat with Q3 2020, reflecting lingering...
EDAP TMS SA to Announce Third Quarter 2021 Financial Results on Wednesday, November 17, 2021
November 10, 2021 08:00 ET
|
EDAP TMS S.A.
Company to host conference call and webcast on Thursday, November 18, at 8:30 am ET LYON, France, November 10, 2021 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound,...
EDAP Announces University of Washington Medicine to Launch Focal One® Robotic HIFU Program
September 28, 2021 08:00 ET
|
EDAP TMS S.A.
Brings advanced focal ablation to prostate cancer patients in the Pacific Northwest LYON, France, September 28, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic...
FluroTest Provides System Development Update; Reports Saliva-based Point of Access Test System and Immunoassay for SARS-CoV-2 Detection is Fully Functional
September 16, 2021 08:00 ET
|
FluroTech Ltd.
CALGARY, Alberta, Sept. 16, 2021 (GLOBE NEWSWIRE) -- FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostic Systems ("FluroTest" or The Company), a diagnostics...
EDAP Announces Presentation of Multiple Abstracts Favorably Comparing HIFU to Surgery at the American Urological Association 2021 Annual Meeting
September 14, 2021 08:00 ET
|
EDAP TMS S.A.
Data demonstrate superiority of HIFU versus radical prostatectomy among prostate cancer patients LYON, France, September 14, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in...
EDAP to Participate at Upcoming Investor Conferences
September 07, 2021 16:35 ET
|
EDAP TMS S.A.
LYON, France, September 7, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), a global leader in robotic energy-based therapies, today announced that management will present at the following investor...
EDAP Reports Second Quarter 2021 Results and Provides Operational Update
August 25, 2021 16:35 ET
|
EDAP TMS S.A.
Total revenue for the first half 2021 of EUR 20.7 million (USD $24.8 million) increased 22.5% over the same period of the prior year Net income was EUR 0.4 million (USD 0.4 million), or EUR 0.01 per...
EDAP Announces Select Preliminary Unaudited Second Quarter 2021 Results
August 04, 2021 08:00 ET
|
EDAP TMS S.A.
Total company second quarter 2021 revenue of approximately EUR 10.4 million (USD $12.4 million) increased 11.8% year-over-year; first half 2021 total company revenue of EUR 20.7 million (USD $24.8...
EDAP Issues Letter to Shareholders
July 20, 2021 08:00 ET
|
EDAP TMS S.A.
Successful financing and hiring of MedTech industry veteran Ryan Rhodes to drive accelerated U.S. expansion efforts LYON, France, July 20, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the...